Genetic Engineering Genetics Drug Development Nanotechnology Vaccine Development Pharmaceuticals Gene Therapy Synthetic Biology Gene Editing Research and Development Tissue Engineering Genomics Drug Discovery Vaccine Technology Microbiology Genetic Research Clinical Trials Stem Cell Research mRNA Technology Cancer Research Pharmaceutical Research Medical Research Molecular Biology Vaccine Research Drug Research Genetic Modification Immunology Therapeutics Protein Engineering Bioengineering Cell Therapy Vaccines Artificial Intelligence Biomedical Engineering Immunotherapy Cloning Cell Culture De-extinction Research Monoclonal Antibodies Medical Technology AI Applications Materials Science Neuroscience Medical Innovations RNA Technology Microbial Biotechnology Food Biotechnology Human Longevity Pharmaceutical Science Biomanufacturing Cloning Technology Research Methods Agricultural Biotechnology Human Enhancement Research Institutions Biosensors Genetic Testing Clinical Research Biomaterials Food Science Cell Biology Reproductive Technology Space Biotechnology Stem Cell Technology RNA Therapeutics Industrial Biotechnology Oncology Plant Biotechnology Microbial Engineering Cultivated Meat mRNA Research Metabolic Engineering Computational Biology Cancer Biology Regenerative Medicine Medical Devices Microfluidics Cellular Biology RNA Interference Antibody Engineering Pharmaceutical Development Bioeconomy Diagnostics Peptide Research Biologics Protein Analysis Health Innovations Microgravity Research Innovative Therapies Biosecurity Chemical Engineering Neurotechnology Proteomics Life Sciences Vaccinology Antibody Development Medical Biotechnology Environmental Biotechnology Genomic Research
The collaboration taps Repertoire’s DECODE platform to supply early T-cell–based programs for Lilly under a risk-sharing model.
